Lipidomics Reveals Associations of Phospholipids With Obesity and Insulin Resistance in Young Adults.

CONTEXT Obesity and related diseases have become a global public health burden. Identifying biomarkers will lead to a better understanding of the underlying mechanisms associated with obesity and the pathways leading to insulin resistance (IR) and diabetes. OBJECTIVE This study aimed to identify the lipidomic biomarkers associated with obesity and IR using plasma samples from a population-based cohort of young adults. DESIGN AND SETTING The Western Australian Pregnancy Cohort (Raine) study enrolled 2900 pregnant women from 1989 to 1991. The 20-year follow-up was conducted between March 2010 and April 2012. Participants and Samples: Plasma samples from 1176 subjects aged 20 years were analyzed using mass spectrometry-based metabolomics. MAIN OUTCOME MEASURES Associations of analytes with markers of obesity and IR including body mass index, waist circumference, homeostasis model assessment (HOMA-IR), and insulin were examined. Analyses were stratified by body mass index and adjusted for lifestyle and other factors. RESULTS Waist circumference was positively associated with seven sphingomyelins and five diacylphosphatidylcholines and negatively associated with two lysophosphatidylcholines. HOMA-IR was negatively associated with two diacylphosphatidylcholines and positively with one lysophosphatidylcholine and one diacylphosphatidylcholine. No significant association was found in the obese/overweight group of the HOMA-IR model. In the normal-weight group, one lysophosphatidylcholine was increased. CONCLUSION A possible discriminative effect of sphingomyelins, particularly those with two double bonds, and lysophosphatidylcholines was identified between subjects with normal weight and obesity independent of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol concentrations. Our results suggest weight status-dependent mechanisms for the development of IR with lysophosphatidylcholine C14:0 as a key metabolite in nonobese IR.

[1]  Tom R. Gaunt,et al.  Maternal pre-pregnancy BMI and gestational weight gain, offspring DNA methylation and later offspring adiposity: findings from the Avon Longitudinal Study of Parents and Children , 2015, International journal of epidemiology.

[2]  P. Rzehak,et al.  Rapid Growth and Childhood Obesity Are Strongly Associated with LysoPC(14:0) , 2014, Annals of Nutrition and Metabolism.

[3]  D. Rader,et al.  Inhibition of Endothelial Lipase Activity by Sphingomyelin in the Lipoproteins , 2014, Lipids.

[4]  P. Holt,et al.  Vitamin D status and predictors of serum 25-hydroxyvitamin D concentrations in Western Australian adolescents , 2014, British Journal of Nutrition.

[5]  R. Sinha,et al.  Human metabolic correlates of body mass index , 2014, Metabolomics.

[6]  Simone Wahl,et al.  Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples , 2014, PloS one.

[7]  L. Beilin,et al.  Oral contraceptive use in girls and alcohol consumption in boys are associated with increased blood pressure in late adolescence , 2013, European journal of preventive cardiology.

[8]  B. Fagerberg,et al.  Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles. , 2013, Biochimica et biophysica acta.

[9]  T. Spector,et al.  Alcohol-induced metabolomic differences in humans , 2013, Translational Psychiatry.

[10]  Fabian J Theis,et al.  Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study , 2013, BMC Medicine.

[11]  P. O’Reilly,et al.  Long-term Leisure-time Physical Activity and Serum Metabolome , 2013, Circulation.

[12]  M. Milburn,et al.  Harnessing the Power of the Immune System to Target Cancer , 2013 .

[13]  J. Brozinick,et al.  Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet , 2012, International Journal of Obesity.

[14]  U. Nöthlings,et al.  Sex Dependency of Human Metabolic Profiles Revisited , 2012 .

[15]  P. Meikle,et al.  Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes , 2012, PloS one.

[16]  Z. Huang,et al.  Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity. , 2012, Biochimica et biophysica acta.

[17]  B. Koletzko,et al.  Nonesterified fatty acid determination for functional lipidomics: comprehensive ultrahigh performance liquid chromatography-tandem mass spectrometry quantitation, qualification, and parameter prediction. , 2012, Analytical chemistry.

[18]  H. Sampath,et al.  The role of stearoyl‐CoA desaturase in obesity, insulin resistance, and inflammation , 2011, Annals of the New York Academy of Sciences.

[19]  Fabian J Theis,et al.  Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers , 2011, PLoS genetics.

[20]  Fredrik Karpe,et al.  Downregulation of Adipose Tissue Fatty Acid Trafficking in Obesity , 2010, Diabetes.

[21]  F. Biro,et al.  Childhood obesity and adult morbidities. , 2010, The American journal of clinical nutrition.

[22]  S. Zubrick,et al.  Adolescent dietary patterns are associated with lifestyle and family psycho-social factors , 2009, Public Health Nutrition.

[23]  M. Lazar,et al.  Mechanisms of obesity-associated insulin resistance: many choices on the menu. , 2007, Genes & development.

[24]  J. Friedman,et al.  Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. , 2005, American journal of physiology. Endocrinology and metabolism.

[25]  S. Park,et al.  Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. , 2005, Metabolism: clinical and experimental.

[26]  R. Ross,et al.  Waist circumference and not body mass index explains obesity-related health risk. , 2004, The American journal of clinical nutrition.

[27]  G. Shulman,et al.  Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction , 2002, European journal of clinical investigation.

[28]  A. Jonas.  Lecithin cholesterol acyltransferase. , 2000, Biochimica et biophysica acta.

[29]  M. Komatsu,et al.  Palmitate and myristate selectively mimic the effect of glucose in augmenting insulin release in the absence of extracellular Ca2+. , 1998, Diabetes.

[30]  F. Stanley,et al.  Effects of frequent ultrasound during pregnancy: a randomised controlled trial , 1993, The Lancet.

[31]  S A Jebb,et al.  Critical evaluation of energy intake data using fundamental principles of energy physiology: 1. Derivation of cut-off limits to identify under-recording. , 1991, European journal of clinical nutrition.

[32]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[33]  S. Grundy,et al.  Increased Low Density Lipoprotein Production Associated with Obesity , 1983, Arteriosclerosis.

[34]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[35]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[36]  Y. Hannun,et al.  An overview of sphingolipid metabolism: from synthesis to breakdown. , 2010, Advances in experimental medicine and biology.

[37]  W. Saris,et al.  Role of stearoyl-CoA desaturases in obesity and the metabolic syndrome , 2008, International Journal of Obesity.

[38]  A. Aljada,et al.  Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.